Th1/Th2 Cytometric Bead Array can discriminate cytokine secretion from endogenously activated cells in pulmonary disease, recent and remote infection in tuberculosis

Cytokine

Volumn 54, Issue 2, 2011, Pages 136-143

  Talat, Najeeha ^a   Shahid, Firdaus ^a   Perry, Sharon ^c   Dawood, Ghaffar ^b   Hussain, Rabia ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Masoomeen General Hospital   (Pakistan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytometric Bead Array; Tuberculosis; Type1 Type2 cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL LOAD; BLOOD ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOMETRIC BEAD ARRAY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HOUSEHOLD; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

COHORT STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG DISEASES; MALE; PRINCIPAL COMPONENT ANALYSIS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS;

EID: 79953043999     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.01.012     Document Type: Article

References (35)

1. WHO. WHO report 2009 country profile; 2009. p. 133-6.
2. Hussain R., Talat N., Shahid F., Dawood G. Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clin Vaccine Immunol 2007, 14(12):1578-1586.
3. WHO UNICEF. Review of national immunization coverage, Pakistan (1980-2008); 2009.
4. Diel R., Nienhaus A., Lange C., Meywald-Walter K., Forssbohm M., Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006, 7(77):1-9.
5. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159(1):15-21.
6. Arend S.M., Engelhard A.C.F., Groot G., De Boer K., Andersen P., Ottenhoff T.H.M., et al. Tuberculin skin testing compared with T-cell response to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diag Lab Immunol 2001, 8(6):1089-1096.
7. Hill P.C., Jackson-Sillah D.J., Fox A., Brookes R.H., de Jong B.C., Lugos M.D., et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 2008, 3(1):e1379.
8. Hasan Z., Jamil B., Ashraf M., Islam M., Dojki M., Irfan M., et al. Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol 2009, 16(7):991-998.
9. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146(5):340-354.
10. Dheda K., Schwander S.K., Zhu B., van Zyl-Smit R.N., Zhang Y. The immunology of tuberculosis: from bench to bedside. Respirology 2010, 15(3):433-450.
11. Denucci C.C., Mitchell J.S., Shimizu Y. Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there. Crit Rev Immunol 2009, 29(2):87-109.
12. Marelli-Berg F.M., Fu H., Vianello F., Tokoyoda K., Hamann A. Memory T-cell trafficking: new directions for busy commuters. Immunology 2010, 130(2):158-165.
13. Barcelos W., Martins-Filho O.A., Guimaraes T.M., Oliveira M.H., Spindola-de-Miranda S., Carvalho B.N., et al. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol Immunol 2006, 50(8):597-605.
14. Tapaninen P., Korhonen A., Pusa L., Seppala I., Tuuminen T. Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence?. Int J Tuberc Lung Dis 2010, 14(3):347-355.
15. Handzel Z.T., Barak V., Altman Y., Bibi H., Lidgi M., Iancovici-Kidon M., et al. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med Assoc J 2007, 9(6):479-483.
16. Verbon A., Juffermans N., Deventer S.J.H., Speelman P., Deutekom H.V., Poll T.V.D. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999, 115:110-113.
17. Deveci F., Akbulut H.H., Turgut T., Muz M.H. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm 2005, 2005(5):256-262.
18. Wynn T.A. T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol 2005, 6(11):1069-1070.
19. Bi Y., Liu G., Yang R. Th17 cell induction and immune regulatory effects Th17 cell induction and immune regulatory effects. J Cell Physiol 2007, 211:273-278.
20. Oliver K.G., Kettman J.R., Fulton R.J. Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin Chem 1998, 44(9):2057-2060.
21. Carson R.T., Vignali D.A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999, 227(1-2):41-52.
22. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004, 110(3):252-266.
23. Maino V.C., Maecker H.T. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens. Clin Immunol 2004, 110(3):222-231.
24. Bozza F.A., Salluh J.I., Japiassu A.M., Soares M., Assis E.F., Gomes R.N., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11(2):R49.
25. Crofton J. Crofton and Douglas respiratory diseases. Clinical features of tuberculosis 1990, Blackwell Scientific, London. 4th ed.
26. Hussain R., Kaleem A., Shahid F., Dojki M., Jamil B., Mehmood H., et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 2002, 264(1-2):95-108.
27. Jolliffe I.T. Principal components analyses 1986, Springer-Verlag, New York.
28. Cattell R.B. The scree plot for the number of factors. Multivariate Behav Res 1966, 1:245-276.
29. Hussain R., Talat N., Shahid F., Dawood G. Biomarker changes associated with tuberculin skin test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts. PLoS ONE 2009, 4(10):e7444.
30. Mueller H., Detjen A.K., Schuck S.D., Gutschmidt A., Wahn U., Magdorf K., et al. Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 2008, 43(2):143-148.
31. Sargentini V., Mariotti S., Carrara S., Gagliardi M.C., Teloni R., Goletti D., et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009, 9:99-108.
32. Talat N., Shahid F., Dawood G., Hussain R. Dynamic changes in biomarker profiles associated with clinical and subclinical tuberculosis in a high transmission setting: a four-year follow-up study. Scand J Immunol 2009, 69(6):537-546.
33. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(7090):235-238.
34. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000, 68(6):3322-3326.
35. Wong H.L., Pfeiffer R.M., Fears T.R., Vermeulen R., Ji S., Rabkin C.S. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008, 17(12):3450-3456.